

Cover Story
Conversation with The Cancer Letter
By Claire Marie Porter and Paul Goldberg
Over the course of his first six months as NCI director, Anthony Letai has contended with federal budget turbulence, a record-setting government shutdown, and concerns about the flow of over research dollars.
Cancer Policy
In Brief


Clinical Roundup
Drugs & Targets
Trending Stories
- Cancer hospitals brace for impact, as CMS moves to slash 340B payments by 33%
- Maura Gillison, who identified the role of HPV in head and neck cancer, changing the standard of care, dies at 61
- The Susan Wojcicki Foundation pushes for rethinking of strategies for early lung cancer detection
- Mail-out colorectal cancer screening programs extend, rather than replace, clinical care
- Vermont researchers discover transmissible cancer in catfish—first ever in a freshwater animal
- Gary Morrow, a pioneer in supportive oncology, dies of prostate cancer complications at 82

















